{"title":"네이버 금융 ─ 뉴스 ─ 실시간 속보","url":"https://finance.naver.com/news/news_list.naver?mode=LSS2D&section_id=101&section_id2=258","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"\"오미크론, 변동성 키울 것\"…월가 주요 은행 전략은?","contents":"<a href=\"/news/news_read.naver?article_id=0001000163&amp;office_id=215&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"&quot;오미크론, 변동성 키울 것&quot;…월가 주요 은행 전략은?\">\"오미크론, 변동성 키울 것\"…월가 주요 은행 전략은?</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0001000163&office_id=215&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638194635820},{"title":"연말 확진자 증가에 오미크론까지…진단키트株 ‘쑥’","contents":"<a href=\"/news/news_read.naver?article_id=0005096535&amp;office_id=018&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"연말 확진자 증가에 오미크론까지…진단키트株 ‘쑥’\">연말 확진자 증가에 오미크론까지…진단키트株 ‘쑥’</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005096535&office_id=018&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638191673178},{"title":"씨티, 머크 투자의견 '매수→중립' 하향…목표주가 85달러","contents":"<a href=\"/news/news_read.naver?article_id=0001000160&amp;office_id=215&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"씨티, 머크 투자의견 '매수→중립' 하향…목표주가 85달러\">씨티, 머크 투자의견 '매수→중립' 하향…목표주가 85달러</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0001000160&office_id=215&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638191673181},{"title":"화이자 백신 공동개발한 바이오엔테크, 오미크론 차단 백신 개발 착수","contents":"<a href=\"/news/news_read.naver?article_id=0004634389&amp;office_id=015&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"화이자 백신 공동개발한 바이오엔테크, 오미크론 차단 백신 개발 착수\">화이자 백신 공동개발한 바이오엔테크, 오미크론 차단 백신 개발 착수</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004634389&office_id=015&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638191673182},{"title":"'미디어 정상화와 미래 비전' 포럼 개최","contents":"<a href=\"/news/news_read.naver?article_id=0001624837&amp;office_id=057&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"'미디어 정상화와 미래 비전' 포럼 개최\">'미디어 정상화와 미래 비전' 포럼 개최</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0001624837&office_id=057&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638191673184},{"title":"30대 임원·40대 CEO 나온다…'뉴삼성' 초석","contents":"<a href=\"/news/news_read.naver?article_id=0001624836&amp;office_id=057&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"30대 임원·40대 CEO 나온다…'뉴삼성' 초석\">30대 임원·40대 CEO 나온다…'뉴삼성' 초석</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0001624836&office_id=057&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638191673186},{"title":"리오토, 3분기 매출 전년비 3배↑…장전 거래서 주가 7.8% 올라","contents":"<a href=\"/news/news_read.naver?article_id=0001000149&amp;office_id=215&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"리오토, 3분기 매출 전년비 3배↑…장전 거래서 주가 7.8% 올라\">리오토, 3분기 매출 전년비 3배↑…장전 거래서 주가 7.8% 올라</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0001000149&office_id=215&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638187739795},{"title":"국민연금, 9월말까지 67.4조 운용 수익...수익률 8%","contents":"<a href=\"/news/news_read.naver?article_id=0003990886&amp;office_id=011&amp;mode=LSS2D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=&amp;date=20211129&amp;page=1\" title=\"국민연금, 9월말까지 67.4조 운용 수익...수익률 8%\">국민연금, 9월말까지 67.4조 운용 수익...수익률 8%</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990886&office_id=011&mode=LSS2D&type=0&section_id=101&section_id2=258&section_id3=&date=20211129&page=1","retrieved":1638187739796}]}